Tag Archives: ONCS

Thursday’s Highlights at Noon: NovaBay Pharma (NBY), Kandi Technologies (KNDI), AVEO Pharma (AVEO), Agios Pharma (AGIO), OncoSec Medical (ONCS)

So far Thursday, May 16, NASDAQ is up 4.23% and the S&P is up 2.81%. Here are this morning’s most active stocks: NovaBay Pharma (NBY – Research Report), Kandi Technologies (KNDI – Research Report), AVEO Pharma (AVEO – Research Report),

Maxim Group Maintains Their Buy Rating on OncoSec Medical (ONCS)

Maxim Group analyst Jason McCarthy maintained a Buy rating on OncoSec Medical (ONCS – Research Report) today and set a price target of $5. The company’s shares opened today at $0.59, close to its 52-week low of $0.42. McCarthy observed:

Tuesday’s Highlights at Noon: American Green Inc (ERBB), Rosetta Genomics Ltd (ROSG), Conatus Pharmaceuticals (CNAT), OncoSec Medical (ONCS), ImmunoCellular Therapeutics (IMUC)

So far Tuesday, January 29, NASDAQ is down -1.77% and the S&P is down -0.11%. Here are this morning’s most active stocks: American Green Inc (ERBB – Research Report), Rosetta Genomics Ltd (ROSG – Research Report), Conatus Pharmaceuticals (CNAT –

Friday’s Midday Stock Update: Navios Maritime Partners Lp (NMM), Cormedix Inc (CRMD), Acelrx (ACRX), OncoSec Medical (ONCS), CDTi Advanced Materials Inc (CDTI)

So far Friday, November 23, NASDAQ is up 0.81% and the S&P is up 0.83%. Here are this morning’s most active stocks: Navios Maritime Partners Lp (NMM – Research Report), Cormedix Inc (CRMD – Research Report), Acelrx (ACRX – Research

Analyst Explains Why They Downgraded Their Rating on OncoSec Medical (ONCS)

In a report released today, Ram Selvaraju from H.C. Wainwright downgraded OncoSec Medical (ONCS – Research Report) to Hold, with a price target of $1. The company’s shares closed yesterday at $0.87, close to its 52-week low of $0.68. Selvaraju

OncoSec Medical (ONCS) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on OncoSec Medical (ONCS – Research Report), with a price target of $5. The company’s shares opened today at $0.79, close to its 52-week low of